Ignite Creation Date:
2024-05-05 @ 11:13 PM
Last Modification Date:
2024-10-26 @ 10:30 AM
Study NCT ID:
NCT01280747
Status:
TERMINATED
Last Update Posted:
2021-01-26
First Post:
2011-01-19
Brief Title:
Examination of Pregabalin Access for Treatment of Indicated Pain Disorders the ExPAND Study
Sponsor:
Pfizers Upjohn has merged with Mylan to form Viatris Inc
Organization:
Pfizer
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-01
Start Date Type:
None
Primary Completion Date:
2012-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-04
Completion Date Type:
ACTUAL
First Submit Date:
2011-01-19
First Submit QC Date:
January 19 2011
Study First Post Date:
2011-01-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-22
Last Update Post Date:
2021-01-26
Last Update Post Date Type:
ACTUAL